Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating complement-associated disorders

Methods for treating complement-associated disorders

US Patent 9771418 · Granted Sep 26, 2017

Estimated economic value: $278,050,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treatment of refractory generalized myasthenia gravis2025
Methods and compositions for treating complement-associated disorders2023
Dosage and administration of anti-C5 antibodies for treatment of protein-losing 2022
Anti-C5A antibodies2022
Risk evaluation and management strategy involving patient follow-ups relating to2022
Risk evaluation and management strategy involving patient follow-ups relating to2022
Reagents and methods for detecting PNH type II white blood cells and their ident2021
Risk evaluation and management strategy involving patient follow-ups relating to2021
Risk evaluation and management strategy involving patient follow-ups relating to2021
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of com2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of com2020
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of com2020